secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
CIK:        0001823239
Form:       8-K
Filed at:   2023-07-20T23:59:59+00:00
Accession:  0001823239-23-000072
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Maravai LifeSciences announces director resignation and appointment of Dr. John DeFord to board
--------------------------------------------------------------------------------

- Robert B. Hance resigned from Board effective July 19, 2023; resignation unrelated to any disagreement with management.
- Dr. John DeFord appointed to Board effective July 20, 2023 to fill vacancy; will serve as Class II director through 2025 annual meeting.
- DeFord is Chairman, CEO and President of Samothrace Medical Innovations; former EVP & CTO of Becton, Dickinson and Company.
- DeFord also serves on boards of Nordson Corporation, NuVasive, and several private medical device companies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1823239/000182323923000072/0001823239-23-000072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1823239/000182323923000072/mrvi-20230719.htm
  HTML page:      https://secwatch.observer/filing/0001823239-23-000072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer